The life sciences software provider raised the capital from Horizons Ventures and Sofinnova Partners to fund commercial growth.
"But to maximize impact, we need to expand access and reach to customers across the globe—at scale. This investment serves as a strong vote of confidence from world-class investors in the biopharmaceutical and innovation technology industries. With their support, we’ll be able to better deploy human and financial capital to help transform scientific dreams into drugs and alternative food sources."
The investment will support expansion in the United States and the ongoing development of the company data platform.
"The whole team is excited to take the next step to further support organisations in driving value from their data, so that they can achieve their business goals. The investment from Octopus Ventures is a fantastic affirmation of the scale of impact we’ve been able to deliver to our customers. We look forward to working with Octopus to further develop our product and expand into new markets."
The seed round was backed by QVentures and various angel investors.
"Empowering product managers, designers and engineers to build the right thing is important. It reduces waste and results in happier customers. It is a problem we are familiar with first and are obsessed with solving."
La Famiglia led the seed investment, which featured backing from several prominent angel investors and venture firms.
"Unlock was just what we needed. From constantly trying to find ways to connect online, to a structured platform that has everything we looked for. The team loved the activities and the connections that were created and reinforced with their colleagues. Unlock is a no-brainer for any remote team and for managers looking for an easy plug n’ play solution to increase remote team satisfaction"
